Xenetic Biosciences(XBIO) - 2025 FY - Earnings Call Transcript

Financial Data and Key Metrics Changes - The meeting reported that proxies were received for 961,887 of the 2,277,139 shares of common stock outstanding, representing approximately 42% of the total shares, which unfortunately does not constitute a quorum for business transactions [3]. Company Strategy and Development Direction - The meeting was adjourned due to the lack of a quorum, and the company's board of directors will determine a new date and time for the 2025 annual stockholders' meeting, indicating ongoing strategic planning and governance [4]. Other Important Information - The company introduced its auditors and legal representatives at the meeting, highlighting the importance of transparency and compliance in corporate governance [1][2]. Summary of Q&A Session - No questions or answers were recorded during this meeting as it was adjourned due to the lack of quorum, preventing any business transactions from taking place [3][4].